Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01411
|
|||||
Drug Name |
ABT-737
|
|||||
Synonyms |
ABT-737; 852808-04-9; ABT 737; ABT737; UNII-Z5NFR173NV; Z5NFR173NV; 4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide; CHEMBL376408; C42H45ClN6O5S2; 4-{4-[(4'-Chlorobiphenyl-2-Yl)methyl]piperazin-1-Yl}-N-{[4-({(1r)-3-(Dimethylamino)-1-[(Phenylthio)methyl]propyl}amino)-3-Nitrophenyl]sulfonyl}benzamide
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Discovery agent [ICD11: N.A.] | Terminated | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C42H45ClN6O5S2
|
|||||
Canonical SMILES |
CN(C)CCC(CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]
|
|||||
InChI |
InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1
|
|||||
InChIKey |
HPLNQCPCUACXLM-PGUFJCEWSA-N
|
|||||
CAS Number |
CAS 852808-04-9
|
|||||
Pharmaceutical Properties | Molecular Weight | 813.4 | Topological Polar Surface Area | 165 | ||
Heavy Atom Count | 56 | Rotatable Bond Count | 15 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 10 | |||
XLogP |
9
|
|||||
PubChem CID | ||||||
PubChem SID |
16311417
, 23409660
, 24771379
, 42307785
, 49700562
, 56311704
, 56314454
, 80047167
, 87557472
, 92729821
, 99003700
, 99431768
, 103505845
, 118043388
, 124756925
, 125163732
, 126582692
, 126723510
, 134344320
, 135262602
, 135727387
, 135727816
, 136367451
, 136920254
, 137220587
, 137507903
, 143499176
, 152236756
, 152258854
, 152344158
, 160647704
, 162011590
, 162037377
, 162202715
, 163391231
, 163685667
, 163842211
, 164045164
, 164194130
, 164834713
, 172087028
, 174007025
, 174316178
, 177748628
, 184814009
, 198934891
, 223683207
, 226522540
, 241155185
, 242585323
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009496) | |||||
2 | The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein. Biochem Biophys Res Commun. 2011 May 6;408(2):344-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.